Based on the important function of PI3K/AKT signaling in glioma development [18, 19] and the crosstalk between SALL4 and PTEN [20], we found that SALL4 mRNA expression was significantly higher in glioma specimens than in non‐cancerous brain samples. The gene discussed is SALL4; the disease is central nervous system cancer.